[1]
H. S. Kim, J. E. Kwon, and Y. J. Park, “Atezolizumab Plus Bevacizumab-induced Recalcitrant Pyoderma Gangrenosum Treated with Baricitinib: A Case Report”, Acta Derm Venereol, vol. 103, p. adv9646, Aug. 2023.